Cell-cycle disturbance and induction of programmed death by new formamidine analogs of daunorubicin.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Anticancer Research

• Publication date

  2014-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 25503143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro induction of apoptosis and necrosis by new derivatives of daunorubicin.

  2013cited by this paper
• Effects of structural modifications of daunorubicin on in vitro antileukemic activity.

  2012cited by this paper
• Cell Death Pathways in Response to Antitumor Therapy

  2009cited by this paper
• DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action.

  2007cited by this paper
• The anthracyclines: When good things go bad

  2007cited by this paper
• Influence of the structure of new anthracycline antibiotics on their biological properties.

  2005cited by this paper
• The cardiotoxicology of anthracycline chemotherapeutics: translating molecular mechanism into preventative medicine.

  2005cited by this paper
• Cytotoxicity, cellular uptake and DNA damage by daunorubicin and its new analogues with modified daunosamine moiety

  2005cited by this paper
• Cell cycle specificity of apoptosis during treatment of leukaemias

  2004cited by this paper
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

  2004cited by this paper
• Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis.

  2003cited by this paper
• Effects of WR-2721 and cyclophosphamide on the cell cycle phase specificity of apoptosis in mouse bone marrow

  2002cited by this paper
• Comparison of anthracycline-induced death of human leukemia cells: Programmed cell death versus necrosis

  2002cited by this paper
• Signaling pathways activated by daunorubicin.

  2001cited by this paper
• Anthracyclines and cardiotoxicity.

  2000cited by this paper
• A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

  1999cited by this paper
• Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells

  1999cited by this paper
• Anthracyclines in the treatment of cancer. An overview.

  1997cited by this paper
• Apoptosis and the cell cycle.

  1995cited by this paper

• Pharmacological p38 MAPK inhibitor SB203580 enhances AML stem cell line KG1a chemosensitivity to daunorubicin by promoting late apoptosis, cell growth arrest in S-phase, and miR-328-3p upregulation

  2024cites this paper
• (Z)-N-(2,6-Diisopropylphenyl)-1-[(2-methoxyphenyl)amino]methanimine oxide

  2024cites this paper
• Differential effects of pesticides on dioxin receptor signaling and p53 activation

  2023cites this paper
• Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia

  2018cites this paper
• Effet des pesticides retrouvés dans l'eau potable du Québec sur deux voies de signalisations cellulaires

  2017cites this paper
• In Vitro Antileukemic Activity of Formamidine Epidoxorubicin Analogs.

  2017cites this paper
• Comparison of in vitro antileukemic activity of obatoclax and ABT-737

  2016cites this paper